Acerta Pharma
Focus: Acerta Pharma is a Netherlands-based small molecule pharmaceutical company founded in 2023, operating across multiple therapeutic areas including oncology, cardiovascular, and pulmonary care. The company is early-stage with a focused pipeline and limited public financial visibility.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Acerta Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Acerta Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ACP-196
Healthy VolunteersClinical Trials (1)
NCT04867980A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult Participants
Phase 1Help build intelligence for Acerta Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.